Even though the NCCN promotes testing for genes like BRCA1/2, which are linked to BC, there is increasing support for more thorough multigene panel testing to avoid missing nearly half of germline mutations, as some studies have shown when physicians only test for the genes mentioned in the NCCN guidelines [4,5,6,7]. This evidence concerns the gene BRCA1 and breast cancer.